avelumab
pfizer,merck
['javelin,bladder', 'javelin,bladder,100', 'urothelial', 'urothelial carcinoma', 'avelumab', 'bladder', 'javelin,100', 'bladder 100']
avelumab first-line maintenance for advanced urothelial carcinoma: results from the javelin bladder 100 trial after 2 years of follow-up #asco23 #asco2023 #oncology 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News